Showing 198,521 - 198,540 results of 252,960 for search '"University"', query time: 1.31s Refine Results
  1. 198521
  2. 198522

    Health Literacy, Label Comprehension, and Consumer Perceptions of Quasi-Drug Information Among Korean Adults: A Cross-Sectional Study by Ko Y, Kim HJ, Lee SM

    Published 2025-01-01
    “…Youngill Ko,1,2,* Heui Jae Kim,3,* Seung-Mi Lee1 1College of Pharmacy, Daegu Catholic University, Gyeongsan, Republic of Korea; 2The Gyeongbuk Pharmaceutical Association, Gumi, Republic of Korea; 3Pharmacy Department, Daehang Hospital, Seoul, Republic of Korea*These authors contributed equally to this workCorrespondence: Seung-Mi Lee, College of Pharmacy, Daegu Catholic University, 13-13 hayang-ro, Hayang-eup, Gyeongsan, 38430, Republic of Korea, Email seungmi2011@gmail.comPurpose: Health literacy (HL) is crucial in understanding labels of healthcare products. …”
    Get full text
    Article
  3. 198523
  4. 198524
  5. 198525
  6. 198526
  7. 198527
  8. 198528
  9. 198529
  10. 198530
  11. 198531
  12. 198532
  13. 198533
  14. 198534

    Antibiofilm and Anticancer Activity of Multi-Walled Carbon Nanotubes Fabricated with Hot-Melt Extruded Astaxanthin-Mediated Synthesized Silver Nanoparticles by You HS, Jang YS, Sathiyaseelan A, Ryu SJ, Lee HY, Baek JS

    Published 2025-01-01
    “…Han-Sol You,1,* Young-Sun Jang,2,* Anbazhagan Sathiyaseelan,1 Su-Ji Ryu,1 Ha-Yeon Lee,1 Jong-Suep Baek1,3 1Department of Bio-Health Convergence, Kangwon National University, Chuncheon, 24341, Republic of Korea; 2College of Pharmacy, Kangwon National University, Chuncheon, 24341, Republic of Korea; 3BeNatureBioLab, Chuncheon, 24206, Republic of Korea*These authors contributed equally to this workCorrespondence: Jong-Suep Baek, Email jsbaek@kangwon.ac.krPurpose: Multi-walled carbon nanotubes (MWCNTs) were used as carriers for silver nanoparticles (AgNPs). …”
    Get full text
    Article
  15. 198535

    Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer by Zhang JN, Li LW, Cao MQ, Liu X, Yi ZL, Liu SS, Liu H

    Published 2025-01-01
    “…Jia-Ning Zhang,1,2,* Lin-Wei Li,1,2,* Man-Qing Cao,1,2,* Xin Liu,1,2 Zi-Lu Yi,1,2 Sha-Sha Liu,1,2 Hong Liu1,2 1The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China; 2Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hong Liu, Email liuhong_submit@tjmuch.comPurpose: Cell division cycle protein 45 (CDC45) plays a crucial role in DNA replication. …”
    Get full text
    Article
  16. 198536

    The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors by Xin Y, Liu N, Peng G, Huang X, Cao X, Zhou X

    Published 2025-01-01
    “…Yujing Xin,1 Ning Liu,2 Gang Peng,3 Xiaoyu Huang,3 Xiaojing Cao,3 Xiang Zhou3 1Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2School of Software, Shandong University, Jinan, Shandong, 250101, People’s Republic of China; 3National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Xiang Zhou, Email zhou.xiang@yeah.netPurpose: To investigate the prognostic value of inflammatory indexes based on peripheral blood cells in unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib combined with PD-1 inhibitors.Methods: This study retrospectively collected baseline inflammatory indexes from HCC patients received Lenvatinib and PD-1 inhibitor-based combination therapy at the Cancer Hospital of the Chinese Academy of Medical Sciences between October 2018 and October 2021. …”
    Get full text
    Article
  17. 198537
  18. 198538
  19. 198539
  20. 198540